首页> 外文期刊>British Journal of Dermatology >Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database
【24h】

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

机译:Malignancies和Ustekinumab:美国食品和药物管理局的分析不良事件报告制度和欧盟药物调节机构药物检修数据库

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《British Journal of Dermatology》 |2017年第5期|共2页
  • 作者单位

    Department of DermatologyNorthwestern University676?N. Saint Clair Street Suite 1600 Chicago IL;

    Department of DermatologyNorthwestern University676?N. Saint Clair Street Suite 1600 Chicago IL;

    Department of DermatologyNorthwestern University676?N. Saint Clair Street Suite 1600 Chicago IL;

    Department of DermatologyNorthwestern University676?N. Saint Clair Street Suite 1600 Chicago IL;

    Developmental Therapeutics ProgramNorthwestern University676?N. Saint Clair Street Suite 1600;

    Department of DermatologyNorthwestern University676?N. Saint Clair Street Suite 1600 Chicago IL;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 皮肤病学与性病学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号